Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
Molecules ; 26(11)2021 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-34204056

RESUMEN

Benign prostatic hypertrophy (BPH) is an intractable chronic inflammatory disease. We studied the efficacy of two ellagitannins, namely camptothin B (1) and cornusiin A (2) that were isolated from Cornus alba (CA) for the treatment of BPH, which is a common health issue in older men. The ellagitannins (1 and 2) were evaluated on its inhibitory activities of the enzyme 5α-reductase and tumor necrosis factor (TNF)-α, its interleukin (IL)-1ß, IL-6, and IL-8 production, and its anti-proliferation and apoptosis induction in prostate cells that show hypertrophy (RWPE-1 cell). In inhibition of 5α-reductase, the ellagitannins (1 and 2) showed potential effects, compared to the positive control, finasteride. In the case of IL-1ß, IL-6, IL-8, and TNF-α, 1 and 2 showed good inhibitory effects as compared to the control group treated with LPS. The ellagitannins (1 and 2) were also shown to inhibit proliferation of, and induce apoptosis in, the RWPE-1 cell. These results suggest that the ellagitannins (1 and 2) may be good candidates for the treatment of BPH.


Asunto(s)
Colestenona 5 alfa-Reductasa/metabolismo , Cornus/química , Taninos Hidrolizables/farmacología , Interleucinas/metabolismo , Hiperplasia Prostática/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Taninos Hidrolizables/química , Taninos Hidrolizables/aislamiento & purificación , Masculino , Estructura Molecular , Hiperplasia Prostática/tratamiento farmacológico , Ratas , Células TH1
2.
Biochem Biophys Res Commun ; 502(1): 145-151, 2018 07 07.
Artículo en Inglés | MEDLINE | ID: mdl-29787750

RESUMEN

The adhesion of cancer cells to the extracellular matrix (ECM) is crucial for cell proliferation, survival, and metastasis. Thus, it is necessary to inhibit cell-ECM adhesion by blocking the activation of the associated signaling to control cancer. Here, we identify erybraedin A (EBA) as a potential Src inhibitor that blocks cell adhesion and viability in non-small-cell lung cancer (NSCLC). EBA significantly inhibited the adhesion of NSCLC cells to fibronectin. EBA also markedly inhibited the activation of Src and its downstream targets, including FAK and Akt. The interaction between integrin ß1 or integrin ß3 and Src was inhibited by EBA treatment. A docking study revealed the bindings of EBA to the ATP-binding pocket and the allosteric regulatory site of the Src kinase. Additionally, EBA markedly inhibited the viability and the colony formation of NSCLC cells and induced apoptotic cell death. These results describe novel biological properties of EBA, which can block the Src-mediated adhesion and survival of NSCLC cells, suggesting the potential of EBA as an anticancer Src inhibitor that warrants further development in advanced preclinical and clinical settings.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Adhesión Celular/efectos de los fármacos , Neoplasias Pulmonares/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/farmacología , Pterocarpanos/farmacología , Familia-src Quinasas/antagonistas & inhibidores , Apoptosis/efectos de los fármacos , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Humanos , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Familia-src Quinasas/metabolismo
3.
Molecules ; 21(2): 137, 2016 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-26805810

RESUMEN

Activity-guided isolation of 80% acetone extract of Cornus alba, which is traditionally used as an anti-inflammatory, hemostatic and diuretic in Korea, yielded one novel compound, tentatively designated cornusiin H (13), together with 12 known compounds. The known compounds included four flavonoids (catechin (1), quercetin-3-O-ß-D-glucuronide (2), quercetin-3-O-ß-D-glucopyranoside (3), kaempferol-3-O-ß-D-glucopyranoside (4)) and eight hydrolysable tannins (gallic acid (5), 2,6-di-O-galloyl-hamamelofuranoside (6), 2-galloyl-4-caffeoyl-L-threonic acid (7) 2,3-di-O-galloyl-4-caffeoyl-L-threonic acid (8), 1,2,3,4,6-penta-O-galloyl-ß-D-glucopyranoside (9), cornusiin B (10), cornusiin A (11) and camptothin B (12)). All compounds exhibited potent 1,1-diphenyl-2-picrylhydrazyl (DPPH)-free radical scavenging activity. Especially, the radical scavenging activities of 6 and 9-13 were higher than that of vitamin C. Compounds 9, 11, 12 and 13 inhibited the production of nitric oxide (NO) in lipopolysaccharide-stimulated RAW264.7 cells to the same degree as N(G)-Monomethyl-L-arginine (L-NMMA). When the antiproliferative effects of the isolated compounds were assessed in prostate cancer cells, the dimeric ellagitannins (11-13) selectively inhibited LNCaP hormone-dependent prostate cancer cells. Flow cytometry analysis indicated that the dimeric ellagitannins induced apoptosis and S-phase arrest. These results suggest that dimeric ellagitannins from Cornus alba can be developed as functional materials or herbal medicines for prostate tumors such as benign prostate hyperplasia and early-stage prostate cancer.


Asunto(s)
Antioxidantes/farmacología , Cornus/química , Citostáticos/farmacología , Taninos Hidrolizables/farmacología , Neoplasias de la Próstata/metabolismo , Animales , Antioxidantes/química , Apoptosis , Línea Celular Tumoral , Citostáticos/química , Citostáticos/aislamiento & purificación , Humanos , Taninos Hidrolizables/química , Taninos Hidrolizables/aislamiento & purificación , Macrófagos/citología , Macrófagos/efectos de los fármacos , Masculino , Ratones , Estructura Molecular , Óxido Nítrico/metabolismo , Neoplasias de la Próstata/tratamiento farmacológico , Células RAW 264.7 , Puntos de Control de la Fase S del Ciclo Celular/efectos de los fármacos
4.
Biol Pharm Bull ; 37(1): 178-83, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24389494

RESUMEN

The roots of Rosa multiflora THUNB. (RM) has been used in oriental traditional medicines as remedies for scabies, rheumatic arthralgia and stomatitis which were practicably related with today's inflammatory and allergic diseases. In the present study, we evaluated whether RM root extract (RME) and its major constituent, 2-(3,4-dihydroxyphenyl)-6-(4-hydroxyphenyl)-8-(2,4-dihydroxyphenyl)-2,3-trans-6,7-cis-7,8-trans-3,4,7,8-tetrahydro-2H,6H-pyrano[2,3-f] chromene-3,7,9-triol (RM-3) belongs to condensed tannins, improve atopic dermatitis (AD)-like skin lesions in NC/Nga mice induced by mite antigen. Topical application of RME as well as RM-3 improved skin severity and suppressed mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) on skin tissues, in addition, significantly reduced T helper 2 (Th2) immune responses via interleukin 10 (IL-10) up-regulation. Thus, RME, contains lots of condensed tannins such as RM-3 which possesses potent anti-inflammtory and immune-modulatory effects, may be useful for treatment of skin allergies and can be developed as new alternative herbal therapy against AD.


Asunto(s)
Dermatitis Atópica/tratamiento farmacológico , Ácaros/inmunología , Fitoterapia , Extractos Vegetales/uso terapéutico , Proantocianidinas/uso terapéutico , Rosa/química , Piel/efectos de los fármacos , Administración Tópica , Animales , Antígenos , Ciclooxigenasa 2/metabolismo , Inhibidores de la Ciclooxigenasa 2/aislamiento & purificación , Inhibidores de la Ciclooxigenasa 2/farmacología , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Dermatitis Atópica/patología , Femenino , Factores Inmunológicos/aislamiento & purificación , Factores Inmunológicos/farmacología , Factores Inmunológicos/uso terapéutico , Interleucina-10/metabolismo , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Extractos Vegetales/química , Extractos Vegetales/farmacología , Raíces de Plantas/química , Proantocianidinas/aislamiento & purificación , Proantocianidinas/farmacología , ARN Mensajero/metabolismo , Índice de Severidad de la Enfermedad , Piel/metabolismo , Piel/patología , Células Th2/metabolismo , Regulación hacia Arriba
5.
Chem Pharm Bull (Tokyo) ; 61(3): 340-3, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23449204

RESUMEN

Three new orcinol (3-hydroxy-5-methylphenol)-conjugated hydrolysable tannins, together with two known compounds were isolated from the leaves of Cleyera japonica (CJ), and have been tentatively named cleyeratannin A (1), cleyeratannin B (2) and cleyeratannin C (3). The chemical structures of these compounds were elucidated using 1 dimensional (1D)/2D NMR and high resolution FAB-MS, and the absolute configuration was confirmed by circular dichroism (CD). To evaluate their anti-oxidative activities, 1,1-diphenyl-2-picrylhydrazyl (DPPH)/free radical scavenging activity and nitroblue tetrazolium (NBT)/superoxide anion scavenging activity were determined.


Asunto(s)
Antioxidantes/química , Depuradores de Radicales Libres/química , Taninos Hidrolizables/química , Extractos Vegetales/química , Resorcinoles/química , Theaceae/química , Nitroazul de Tetrazolio/química , Superóxidos/química
6.
Molecules ; 17(10): 11484-94, 2012 Sep 27.
Artículo en Inglés | MEDLINE | ID: mdl-23018923

RESUMEN

Isolation of compounds from the root of Rhodiola sachalinensis (RRS) yielded tyrosol (1), salidroside (2), multiflorin B (3), kaempferol-3,4'-di-O-ß-D-glucopyranoside (4), afzelin (5), kaempferol (6), rhodionin (7), and rhodiosin (8). Quantification of these compounds was performed by high-performance liquid chromatography (HPLC). To investigate the antioxidant and anti-inflammatory effects of the compounds, DPPH radical scavenging, NBT superoxide scavenging and nitric oxide production inhibitory activities were examined in LPS-stimulated Raw 264.7 cells. We suggest that the major active components of RRS are herbacetin glycosides, exhibiting antioxidant activity, and kaempferol, exhibiting anti-inflammatory activity.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Fenoles/farmacología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Raíces de Plantas/química , Rhodiola/química , Compuestos de Bifenilo/antagonistas & inhibidores , Línea Celular , Supervivencia Celular/efectos de los fármacos , Humanos , Óxido Nítrico/biosíntesis , Picratos/antagonistas & inhibidores , Superóxidos/antagonistas & inhibidores
7.
Phytother Res ; 25(9): 1301-5, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21312305

RESUMEN

The roots of Rhododendron mucronulatum Turzaninov have been used in Oriental traditional medicine for the treatment of dysuria, fever, increase of digestive activity and tonics in China and Korea. Activity guided isolation of the roots of Rhododendron mucronulatum Turzaninov has led to the isolation of three flavonoids, one flavan 3-ol and one proanthocyanidin. Chemical investigation of the 80% Me2 CO extract from the roots of Rhododendron mucronulatum led to the isolation and identification of five compounds: taxifolin (1), taxifolin 3-O-ß-D-glucopyranoside (2), quercetin 3-O-α-L-arabinofuranoside (3), (-)-epicatechin (4), procyanidin B-3 (5). To investigate the antioxidative and antiinflammatory effects of these compounds, their 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities and the protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated HaCaT cells were also quantified by western blotting and their end products, nitric oxide (NO) and prostaglandin E2 (PGE2 ), respectively. Compounds (1-5) showed potent DPPH radical scavenging compared with positive controls (L-ascorbic acid). Also, compounds 1 and 2 dose-dependently inhibited the expressions of inflammatory mediators, NO and PGE2 , suggesting they are promising candidates as antiinflammatory agents.


Asunto(s)
Inhibidores de la Ciclooxigenasa/farmacología , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Extractos Vegetales/farmacología , Rhododendron/química , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Arabinosa/análogos & derivados , Arabinosa/farmacología , Biflavonoides/farmacología , Catequina/farmacología , Línea Celular , Ciclooxigenasa 2/metabolismo , Dinoprostona/metabolismo , Glucósidos/farmacología , Humanos , Óxido Nítrico/metabolismo , Raíces de Plantas/química , Proantocianidinas/farmacología , Quercetina/análogos & derivados , Quercetina/farmacología
8.
Phytother Res ; 25(10): 1564-9, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21717518

RESUMEN

Recently, the isolation of several condensed tannins from the roots of Rosa multiflora Thunberg, a traditional herbal therapy in oriental medicine for rheumatoid arthritis and scabies, was described. Two of the major condensed tannins - procyanidin B-3 (ProB3) and ent-guibourtinidol-(4ß â†’ 6)-catechin (RM-1) - were then applied topically to atopic dermatitis-like skin lesions on NC/Nga mice in order to assess their immunomodulatory properties. Both ProB3 and RM-1 significantly reduced the serum levels of eosinophils, IgE and certain Th2 cytokines (IL-4, 5 and 13) (p < 0.05 or 0.01). Additionally, ProB3 and RM-1 significantly reduced both the mRNA and protein expression of COX-2 and iNOS in mouse skin tissues (p < 0.01). Such results strongly suggest that ProB3 and RM-1 may be useful in the treatment allergic skin conditions, most notably atopic dermatitis.


Asunto(s)
Biflavonoides/uso terapéutico , Catequina/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Factores Inmunológicos/farmacología , Fitoterapia , Extractos Vegetales/uso terapéutico , Proantocianidinas/uso terapéutico , Rosa/química , Administración Tópica , Animales , Biflavonoides/farmacología , Catequina/análogos & derivados , Catequina/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Inhibidores de la Ciclooxigenasa/uso terapéutico , Citocinas/sangre , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Eosinófilos/metabolismo , Femenino , Inmunoglobulina E/sangre , Factores Inmunológicos/uso terapéutico , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Extractos Vegetales/farmacología , Raíces de Plantas , Proantocianidinas/farmacología , ARN Mensajero/metabolismo , Piel/efectos de los fármacos , Piel/inmunología , Piel/patología , Células Th2/metabolismo
9.
Clin Dev Immunol ; 2010: 618517, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21197410

RESUMEN

Atopic dermatitis (AD) is a common inflammatory skin disease. The increasing prevalence and severity of AD have prompted the developments of safer, more effective drugs. Although topical corticosteroids have been used as first line therapy for AD, their potential side effects limit their clinical applications. To investigate the effect of hirsutenone (HIR), a diarylheptanoid compound, on AD-like skin lesions and other factors related to immune response is the aim of this paper Th2-related cytokines (IL-4, IL-5, IL-13), eosinophil, IgE inflammatory factors (COX-2, iNOS) levels were reduced in blood, lymphocytes, and tissue after HIR treatment. These results suggest that HIR might be an effective treatment for AD.


Asunto(s)
Catecoles/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/patología , Diarilheptanoides/uso terapéutico , Piel/patología , Administración Cutánea , Animales , Catecoles/administración & dosificación , Catecoles/síntesis química , Ciclooxigenasa 2/sangre , Diarilheptanoides/administración & dosificación , Diarilheptanoides/síntesis química , Diarilheptanoides/aislamiento & purificación , Modelos Animales de Enfermedad , Eosinófilos/efectos de los fármacos , Femenino , Inmunoglobulina E/sangre , Inyecciones Intraperitoneales , Interleucinas/sangre , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/sangre
10.
Phytother Res ; 24(7): 1071-7, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20041431

RESUMEN

Increased levels of eosinphils, IgE, IL-4, 5, and 13 and pro-inflammatory factors (COX-2, iNOS) are observed in patients with atopic dermatitis (AD). Taxifolin 3-O-beta-D-glucopyranoside (TAX) from the roots of Rhododendron mucronulatum (RM) was examined to determine whether its immunomodulatory effect was applicable for treating atopic dermatitis.A total of 7 groups of NC/Nga mice with AD were treated by topical application or intraperitoneal injection of TAX for 4 weeks. Follow-up evaluations were done to assess the changes in clinical observations, eosinophil counts, and levels of IgE, cytokines, COX-2 and iNOS.In the clinical observation during the experimental period, TAX treatment significantly reduced the severity of AD-like lesions induced in NC/Nga mice. Eosinophil and IgE levels decreased after treatment of the animals with TAX. TAX may thus be associated with improvement of eosinophil-related allergic diseases. The expression of cytokines (IL-4, 5 and 13) was significantly inhibited in the TAX-treated group, suggesting that TAX might play an immunoregulatory role associated with AD. In RT-PCR, iNOS and COX-2 expression levels were reduced in the TAX-treated group. In western blotting, the expression levels of iNOS and COX-2 were also reduced in the TAX-treated group.These findings suggest that TAX is effective for the treatment of AD by preventing the production of inflammatory cytokines and by reducing skin inflammation.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Dermatitis Atópica/tratamiento farmacológico , Glicósidos/farmacología , Quercetina/análogos & derivados , Piel/efectos de los fármacos , Animales , Ciclooxigenasa 2/análisis , Ciclopropanos , Citocinas/sangre , Modelos Animales de Enfermedad , Eosinófilos/inmunología , Femenino , Inmunoglobulina E/sangre , Inflamación/tratamiento farmacológico , Inflamación/patología , Ratones , Óxido Nítrico Sintasa de Tipo II/análisis , Extractos Vegetales/farmacología , Raíces de Plantas/química , Quercetina/farmacología , Rhododendron/química , Piel/patología
11.
Chem Pharm Bull (Tokyo) ; 58(9): 1227-31, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20823605

RESUMEN

Three new stereoisomers of condensed tannins (1-3), and four known phenolic compounds (4-7) were isolated from the 80% acetone extract of the roots of Rosa multiflora Thunberg. The structures of these compounds were elucidated using 1D/2D NMR, high resolution (HR)-MS, and circular dichroism (CD) spectra. In order to evaluate their anti-oxidative and anti-inflammatory activities, their 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity and inhibitory activity on nitric oxide (NO) production were determined.


Asunto(s)
Antiinflamatorios/química , Antiinflamatorios/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Proantocianidinas/química , Proantocianidinas/farmacología , Rosa/química , Animales , Antiinflamatorios/aislamiento & purificación , Antioxidantes/aislamiento & purificación , Compuestos de Bifenilo/metabolismo , Línea Celular , Supervivencia Celular/efectos de los fármacos , Radicales Libres/metabolismo , Macrófagos/citología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Ratones , Óxido Nítrico/inmunología , Picratos/metabolismo , Raíces de Plantas/química , Proantocianidinas/aislamiento & purificación , Estereoisomerismo
12.
Anticancer Res ; 40(1): 323-333, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31892583

RESUMEN

BACKGROUND/AIM: Despite the Warburg effect, mitochondria play an essential role in the survival and maintenance of cancer cells. Thus, mitochondria have been considered a target for anticancer agents. Here, we identified a mitochondria-targeting anticancer agent from natural products. MATERIALS AND METHODS: Morphological and functional changes in mitochondria were determined by a fluorescence-based High Content Imaging System. Using human non-small cell lung cancer (NSCLC) cell lines (H1299, H226B, and A549), cell viability and colony formation assays, cell cycle analysis, and immunoblotting were performed to determine cytotoxic and proapoptotic effects of papuamine. RESULTS: Using a natural product chemical library, we identified papuamine as an active compound to inhibit viability and ATP production of NSCLC cells. Papuamine depleted intracellular ATP by causing mitochondrial dysfunction, as indicated by the loss of the mitochondrial membrane potential and increased mitochondrial superoxide generation. Papuamine significantly inhibited viability and colony formation of NSCLC cells by inducing apoptosis. CONCLUSION: Papuamine has a potential as a novel mitochondria-targeting anticancer agent.


Asunto(s)
Alcaloides/uso terapéutico , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Mitocondrias/patología , Células A549 , Adenosina Trifosfato/metabolismo , Adenilato Quinasa/metabolismo , Alcaloides/química , Alcaloides/farmacología , Carcinoma de Pulmón de Células no Pequeñas/patología , Supervivencia Celular/efectos de los fármacos , Humanos , Neoplasias Pulmonares/patología , Mitocondrias/efectos de los fármacos , Ensayo de Tumor de Célula Madre , Regulación hacia Arriba/efectos de los fármacos
13.
Biol Pharm Bull ; 32(12): 2029-33, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19952423

RESUMEN

Activity guided fractionation of Aconitum koreanum root extract (RAK), a traditional medicine in Korea, afforded four caffeoyl derivatives, caffeic acid (1), 4,5-dicaffeoylquinic acid (2), 3,5-dicaffeoylquinic acid (3) and 3,5-dicaffeoylquinic acid methyl ester (4). In order to evaluate the anti-oxidative and anti-inflammatory effects of these compounds, their 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities and abilities to inhibit nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW 264.7 were examined. And the protein and mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated HaCaT cells were also quantified by Western blotting and reverse transcription-polymerase chain reaction (RT-PCR). Compounds (1-4) showed potent DPPH radical scavenging and NO inhibitory activities as compared with positive controls (L-ascorbic acid and N(G)-monomethyl-L-arginine (L-NMMA), respectively). Also, these compounds dose-dependently inhibited the expressions of iNOS and COX-2 as well as their mRNA levels.


Asunto(s)
Aconitum/química , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Ácidos Cafeicos/farmacología , Óxido Nítrico/antagonistas & inhibidores , Extractos Vegetales/farmacología , Animales , Compuestos de Bifenilo , Western Blotting , Técnicas de Cultivo de Célula , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Queratinocitos/efectos de los fármacos , Lipopolisacáridos , Macrófagos/efectos de los fármacos , Ratones , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/metabolismo , Picratos , Extractos Vegetales/química , Raíces de Plantas , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
14.
Cell Death Dis ; 10(11): 810, 2019 10 24.
Artículo en Inglés | MEDLINE | ID: mdl-31649278

RESUMEN

Mitochondria play a pivotal role in cancer bioenergetics and are considered a potential target for anticancer therapy. Considering the limited efficacy and toxicity of currently available mitochondria-targeting agents, it is necessary to develop effective mitochondria-targeting anticancer drugs. By screening a large chemical library consisting of natural products with diverse chemical entities, we identified gracillin, a steroidal saponin, as a mitochondria-targeting antitumor drug. Gracillin displayed broad-spectrum inhibitory effects on the viability of a large panel of human cancer cell lines, including those carrying acquired resistance to chemotherapy or EGFR-targeting drugs, by inducing apoptosis. We show that gracillin attenuates mitochondria-mediated cellular bioenergetics by suppressing ATP synthesis and by producing reactive oxygen species (ROS). Mechanistically, gracillin disrupts complex II (CII) function by abrogating succinate dehydrogenase (SDH) activity without affecting the succinate:ubiquinone reductase. The gracillin-induced cell death was potentiated by 3-nitropropionic acid (3-NPA) or thenoyltrifluoroacetone (TTFA), which inhibit CII by binding to the active site of SDHA or to the ubiquinone-binding site, respectively. Finally, we show that gracillin effectively suppressed the mutant-Kras-driven lung tumorigenesis and the growth of xenograft tumors derived from cell lines or patient tissues. Gracillin displayed no obvious pathophysiological features in mice. Collectively, gracillin has potential as a CII-targeting antitumor drug.


Asunto(s)
Carcinogénesis/genética , Muerte Celular/efectos de los fármacos , Neoplasias Pulmonares/tratamiento farmacológico , Espirostanos/farmacología , Animales , Apoptosis/efectos de los fármacos , Carcinogénesis/efectos de los fármacos , Muerte Celular/genética , Complejo II de Transporte de Electrones/genética , Xenoinjertos , Humanos , Neoplasias Pulmonares/genética , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/genética , Nitrocompuestos/metabolismo , Oxidación-Reducción , Propionatos/metabolismo , Especies Reactivas de Oxígeno , Tenoiltrifluoroacetona/metabolismo
15.
Arch Pharm Res ; 31(4): 424-8, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18449498

RESUMEN

Chemical investigation of the 80% Me(2)CO extract from the seeds of Prunus tomentosa led to the isolation and identification of six flavonoids: kaempferol (1), kaempferol 3-O-alpha-L-rhamnopyranoside (2; afzelin), kaempferol 3-O-beta-D-(6-acetyl)-glucopyranosyl(1-->4)-alpha-L-rhamnopyranoside (3; multiflorin A), kaempferol 3-O-beta-D-glucopyranosyl(1-->4)-alpha-L-rhamnopyranoside (4; multiflorin B), quercetin 3-O-alpha-L-rhamnopyranoside (5; quercitrin), and quercetin 3-O-beta-D-glucopyranosyl (1-->4)-alpha-L-rhamnopyranoside (6; multinoside A). Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E(2) production in interferon-gamma (INF-gamma) and lipopolysaccharide (LPS)-activated RAW 264.7 cells in vitro (COX-2) of the isolated compounds were evaluated. Compounds 1, 5, and 6 exhibited potent anti-oxidative activity in the DPPH radical scavenging assay with IC(50) values of 57.2, 59.4, and 54.3 microg/mL respectively. The positive control, ascorbic acid, had an IC(50) of 55.5 mug/mL. Compounds 1, 5, and 6 also reduced COX-2 levels in a dose dependent manner with IC(50) values of 10.2, 8.7, and 9.6 microg/mL respectively, with the positive control, indomethacin, having an IC(50) of 5.1 microg/mL. All six compounds inhibited NO production in a dose dependent manner with IC(50) values of 35.1, 42.8, 40.0, 44.8, 43.7, and 43.9 microg/mL respectively, while the positive control, L-NMMA, had an IC(50) of 42.1 microg/mL.


Asunto(s)
Inhibidores de la Ciclooxigenasa 2/farmacología , Ciclooxigenasa 2/metabolismo , Dinoprostona/metabolismo , Inhibidores Enzimáticos/farmacología , Flavonoides/farmacología , Depuradores de Radicales Libres/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico/metabolismo , Prunus , Animales , Supervivencia Celular/efectos de los fármacos , Cromonas/farmacología , Inhibidores de la Ciclooxigenasa 2/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/aislamiento & purificación , Flavonoides/aislamiento & purificación , Depuradores de Radicales Libres/aislamiento & purificación , Glicósidos/farmacología , Indometacina/farmacología , Interferón gamma/metabolismo , Quempferoles/farmacología , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/enzimología , Manósidos/farmacología , Ratones , Estructura Molecular , Óxido Nítrico Sintasa/metabolismo , Proantocianidinas/farmacología , Prunus/química , Quercetina/análogos & derivados , Quercetina/farmacología , Semillas , omega-N-Metilarginina/farmacología
16.
Artículo en Inglés | MEDLINE | ID: mdl-28348624

RESUMEN

Chromatographic isolation of the 80% MeOH extract of Acer ginnala (AG) yielded seven galloyl derivatives: gallic acid (1), ginnalin B (2), acertannin (3), maplexin D (4), maplexin E (5), quercetin-3-O-(2''-galloyl)-α-L-rhamnopyranoside (6), and kaempferol-3-O-(2''-galloyl)-α-L-rhamnopyranoside (7). This is the first study to report the isolation of compounds 4 and 5 from AG. Galloyl derivatives 3-7 exhibited potent radical scavenging activities, with 5 and 7 showing particularly strong inhibitory activities against nitric oxide production in lipopolysaccharides- (LPS-) stimulated RAW264.7 cells. In addition, oral administration of AG extract (500 mg/kg b.w.) improved symptoms of hyperglycemia and blunted the increases in serum GOT/GPT levels in a rat model of streptozotocin-induced diabetes. These results suggest that galloyl derivatives (1-7) are antioxidant and anti-inflammatory agents and that AG extract has potential as a functional material or novel herbal medicine for treating diabetes mellitus.

17.
Clin Cancer Res ; 23(5): 1299-1311, 2017 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-27582487

RESUMEN

Purpose: Histone deacetylase inhibitors (HDI) are promising anticancer therapies; however, drug resistance limits their efficacy. Here, we investigated the molecular mechanisms underlying HDI resistance, focusing on the mechanism of HDI-mediated induction of insulin-like growth factor 2 (IGF2) based on our previous study.Experimental Design: The methylation status of CCCTC-binding factor (CTCF)-binding sites in the IGF2/H19 imprinting control region (ICR) were determined by methylation-specific PCR and bisulfite sequencing. The effectiveness of single or combinatorial blockade of DNA methyltransferase 1 (DNMT1) and histone deacetylase (HDAC) was evaluated using cell viability assay and patient-derived tumor xenograft (PDX) model.Results: HDAC inhibition by vorinostat increased acetylated STAT3 (K685), resulting in transcriptional upregulation of DNMT1 DNMT1-mediated hypermethylation of CTCF-binding sites in the IGF2/H19 ICR decreased CTCF insulator activity, leading to a transcriptional upregulation of IGF2 and activation of the insulin-like growth factor 1 receptor (IGF-1R) pathway in cells with acquired or de novo vorinostat resistance. Strategies targeting DNMT1 diminished the IGF2 expression and potentiated vorinostat sensitivity in preclinical models of lung cancer with hypermethylation in the H19/IGF2 ICR. The degree of ICR hypermethylation correlated with vorinostat resistance in patient-derived lung tumors and in patients with hematologic malignancies.Conclusions: DNMT1-mediated transcriptional upregulation of IGF2 is a novel mechanism of resistance to HDIs, highlighting the role of epigenetic deregulation of IGF2 in HDI resistance and the potential value of the H19/IGF2 ICR hypermethylation and DNMT1 expression as predictive biomarkers in HDI-based anticancer therapies. Clin Cancer Res; 23(5); 1299-311. ©2016 AACR.


Asunto(s)
ADN (Citosina-5-)-Metiltransferasa 1/genética , Neoplasias Hematológicas/tratamiento farmacológico , Factor II del Crecimiento Similar a la Insulina/genética , Neoplasias Pulmonares/genética , ARN Largo no Codificante/genética , Animales , Factor de Unión a CCCTC/genética , Metilación de ADN/genética , Resistencia a Antineoplásicos/genética , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Neoplasias Hematológicas/genética , Neoplasias Hematológicas/patología , Inhibidores de Histona Desacetilasas/efectos adversos , Histona Desacetilasas/genética , Humanos , Ácidos Hidroxámicos/administración & dosificación , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/secundario , Ratones , Factor de Transcripción STAT3/genética , Vorinostat , Ensayos Antitumor por Modelo de Xenoinjerto
18.
Nat Prod Res ; 30(2): 206-13, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26211877

RESUMEN

Two new phenolic compounds, 4-O-glucopyranosyl-5-O-caffeoylshikimic acid (1) and 2,3-digalloyl oregonin (2), were isolated along with eight known phenolic compounds (3-10) from an 80% acetone extract of Alnus sibirica leaves. The chemical structures of these compounds were elucidated using 1D/2D nuclear magnetic resonance and high resolution-MS. The anti-oxidative activities of these compounds were determined by assaying their 1,1-diphenyl-2-picrylhydrazyl radical and nitroblue tetrazolium superoxide anion scavenging activity. All of the isolated phenolic compounds (1-10) exhibited potent anti-oxidative activities. In particular, 2 and 4, which are diarylheptanoids, and 10 which is ellagitannin exhibited excellent anti-oxidative activities with almost the same potency as that of the positive controls L-ascorbic acid and allopurinol.


Asunto(s)
Alnus/química , Antioxidantes/química , Antioxidantes/farmacología , Diarilheptanoides/química , Ácido Gálico/análogos & derivados , Glucósidos/química , Hojas de la Planta/química , Ácido Shikímico/análogos & derivados , Ácido Ascórbico/farmacología , Compuestos de Bifenilo/química , Diarilheptanoides/farmacología , Evaluación Preclínica de Medicamentos/métodos , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Ácido Gálico/química , Ácido Gálico/farmacología , Glucósidos/farmacología , Taninos Hidrolizables/farmacología , Espectroscopía de Resonancia Magnética , Fenoles/química , Picratos/química , Extractos Vegetales/química , Ácido Shikímico/química , Ácido Shikímico/farmacología , Superóxidos/química
19.
Cancer Res ; 76(3): 686-99, 2016 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-26645561

RESUMEN

The Hsp90 facilitates proper folding of signaling proteins associated with cancer progression, gaining attention as a target for therapeutic intervention. The natural rotenoid deguelin was identified as an Hsp90 inhibitor, but concerns about neurotoxicity have limited prospects for clinical development. In this study, we report progress on deguelin analogues that address this limitation, focusing on the novel analogue SH-1242 as a candidate to broadly target human lung cancer cells, including those that are chemoresistant or harboring KRAS mutations. In a KRAS-driven mouse model of lung cancer, SH-1242 administration reduced tumor multiplicity, volume, and load. Similarly, in human cell line-based or patient-derived tumor xenograft models, SH-1242 induced apoptosis and reduced tumor vasculature in the absence of detectable toxicity. In contrast to deguelin, SH-1242 toxicity was greatly reduced in normal cells and when administered to rats did not produce obvious histopathologic features in the brain. Mechanistic studies revealed that SH-1242 bound to the C-terminal ATP-binding pocket of Hsp90, disrupting the ability to interact with its co-chaperones and clients and triggering a degradation of client proteins without affecting Hsp70 expression. Taken together, our findings illustrate the superior properties of SH-1242 as an Hsp90 inhibitor and as an effective antitumor and minimally toxic agent, providing a foundation for advancing further preclinical and clinical studies.


Asunto(s)
Antineoplásicos/farmacología , Benzopiranos/farmacología , Proteínas HSP90 de Choque Térmico/antagonistas & inhibidores , Animales , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Proteínas HSP90 de Choque Térmico/metabolismo , Humanos , Ratones , Ratones Transgénicos , Ratas , Ratas Sprague-Dawley , Ensayos Antitumor por Modelo de Xenoinjerto
20.
J Dermatol Sci ; 77(3): 166-72, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25617237

RESUMEN

BACKGROUND: Quercetin-3-O-(2″-gallate)-α-l-rhamnopyranoside (QGR) is a new quercetin derivative which is isolated from the leaves of Acer ginnala Maxim, a native plant of Korea. Quercetin has several biological effects including antioxidative, anti-inflammatory, and anti-allergic effects. However, the topical effect of QGR on atopic dermatitis (AD) like skin lesion in NC/Nga mice has not been studied. OBJECTIVE: To evaluate the anti-inflammatory and anti-allergic effect of QGR in a murine model of atopic dermatitis. METHODS: We measured inducible nitric oxide synthase (iNOS) and cyclooxygenase -2(COX-2) level in RAW264.7 cell with QGR treatment. And after induction of AD like skin lesions with Dermatophagoides farina (Df) ointment, mice were treated with QGR and control drugs. Clinical scores, interleukin (IL) 4, 5, and 13, serum IgE, eosinophil levels, iNOS and COX-2 level were evaluated. RESULTS: Results show that mRNA level of iNOS and COX-2 in vitro were decreased after QGR treatment. Topical QGR markedly decreased the iNOS and COX-2 mRNA expressions in the skin. QGR also significantly suppressed the increase in the level of total plasma IgE and eosinophils. In addition, topical application of QGR down-regulated the expressions of the cytokines, IL-4,5 and 13, which were induced by Df ointment stimulation. CONCLUSIONS: In the present study, we showed that topical application of QGR ameliorated Df-induced AD-like inflammatory responses in NC/Nga mice. These results demonstrate that QGR might be beneficial in the treatment of AD.


Asunto(s)
Ciclooxigenasa 2/metabolismo , Dermatitis Atópica/tratamiento farmacológico , Eosinófilos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Quercetina/análogos & derivados , Administración Cutánea , Animales , Células Cultivadas , Ciclooxigenasa 2/efectos de los fármacos , Ciclooxigenasa 2/genética , Dermatitis Atópica/sangre , Dermatitis Atópica/enzimología , Femenino , Inmunoglobulina E/sangre , Interleucina-13/sangre , Interleucina-4/sangre , Interleucina-5/sangre , Recuento de Leucocitos , Macrófagos/efectos de los fármacos , Macrófagos/enzimología , Ratones , Óxido Nítrico Sintasa de Tipo II/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/genética , Peptidoglicano/farmacología , Quercetina/administración & dosificación , Quercetina/uso terapéutico , ARN Mensajero/metabolismo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda